Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1991 4
1992 1
1993 2
1994 5
1995 4
1996 2
1997 2
1998 4
1999 3
2000 3
2001 5
2002 5
2003 2
2004 5
2005 10
2006 12
2007 12
2008 7
2009 9
2010 11
2011 4
2012 7
2013 10
2014 6
2015 15
2016 17
2017 13
2018 14
2019 9
2020 13
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

206 results
Results by year
Filters applied: . Clear all
Page 1
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, Jordan RCK, Zhao W, Sturgis EM, Burtness B, Ridge JA, Ringash J, Galvin J, Yao M, Koyfman SA, Blakaj DM, Razaq MA, Colevas AD, Beitler JJ, Jones CU, Dunlap NE, Seaward SA, Spencer S, Galloway TJ, Phan J, Dignam JJ, Le QT. Gillison ML, et al. Among authors: harari pm. Lancet. 2019 Jan 5;393(10166):40-50. doi: 10.1016/S0140-6736(18)32779-X. Epub 2018 Nov 15. Lancet. 2019. PMID: 30449625 Free PMC article. Clinical Trial.
Targeting AKT/PKB to improve treatment outcomes for solid tumors.
Iida M, Harari PM, Wheeler DL, Toulany M. Iida M, et al. Among authors: harari pm. Mutat Res. 2020 Jan-Apr;819-820:111690. doi: 10.1016/j.mrfmmm.2020.111690. Epub 2020 Feb 20. Mutat Res. 2020. PMID: 32120136 Free PMC article. Review.
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: harari pm. N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422. N Engl J Med. 2006. PMID: 16467544 Free article. Clinical Trial.
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK. Bonner JA, et al. Among authors: harari pm. Lancet Oncol. 2010 Jan;11(1):21-8. doi: 10.1016/S1470-2045(09)70311-0. Epub 2009 Nov 10. Lancet Oncol. 2010. PMID: 19897418 Clinical Trial.
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.
Thomson DJ, Palma D, Guckenberger M, Balermpas P, Beitler JJ, Blanchard P, Brizel D, Budach W, Caudell J, Corry J, Corvo R, Evans M, Garden AS, Giralt J, Gregoire V, Harari PM, Harrington K, Hitchcock YJ, Johansen J, Kaanders J, Koyfman S, Langendijk JA, Le QT, Lee N, Margalit D, Mierzwa M, Porceddu S, Soong YL, Sun Y, Thariat J, Waldron J, Yom SS. Thomson DJ, et al. Among authors: harari pm. Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627. doi: 10.1016/j.ijrobp.2020.04.016. Epub 2020 Apr 14. Int J Radiat Oncol Biol Phys. 2020. PMID: 32302681 Free PMC article.
Life Beyond COVID: Pay Attention to Viruses.
Harari PM, Lambert PF. Harari PM, et al. Int J Radiat Oncol Biol Phys. 2020 Oct 1;108(2):348-350. doi: 10.1016/j.ijrobp.2020.07.001. Int J Radiat Oncol Biol Phys. 2020. PMID: 32890509 Free PMC article. No abstract available.
Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology.
Bristow RG, Alexander B, Baumann M, Bratman SV, Brown JM, Camphausen K, Choyke P, Citrin D, Contessa JN, Dicker A, Kirsch DG, Krause M, Le QT, Milosevic M, Morris ZS, Sarkaria JN, Sondel PM, Tran PT, Wilson GD, Willers H, Wong RKS, Harari PM. Bristow RG, et al. Among authors: harari pm. Lancet Oncol. 2018 May;19(5):e240-e251. doi: 10.1016/S1470-2045(18)30096-2. Lancet Oncol. 2018. PMID: 29726389 Review.
Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.
Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Rotman M, Khuntia D, Straube W, Zhang Q, Ang K. Harari PM, et al. J Clin Oncol. 2014 Aug 10;32(23):2486-95. doi: 10.1200/JCO.2013.53.9163. Epub 2014 Jul 7. J Clin Oncol. 2014. PMID: 25002723 Free PMC article. Clinical Trial.
The Promise of Combining Radiation Therapy With Immunotherapy.
Jagodinsky JC, Harari PM, Morris ZS. Jagodinsky JC, et al. Among authors: harari pm. Int J Radiat Oncol Biol Phys. 2020 Sep 1;108(1):6-16. doi: 10.1016/j.ijrobp.2020.04.023. Epub 2020 Apr 23. Int J Radiat Oncol Biol Phys. 2020. PMID: 32335187 Free article. Review.
Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).
Eisbruch A, Harris J, Garden AS, Chao CK, Straube W, Harari PM, Sanguineti G, Jones CU, Bosch WR, Ang KK. Eisbruch A, et al. Among authors: harari pm. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1333-8. doi: 10.1016/j.ijrobp.2009.04.011. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540060 Free PMC article.
206 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page